1. Amyloid β Peptide Compromises Neural Stem Cell Fate by Irreversibly Disturbing Mitochondrial Oxidative State and Blocking Mitochondrial Biogenesis and Dynamics.
- Author
-
Ribeiro MF, Genebra T, Rego AC, Rodrigues CMP, and Solá S
- Subjects
- Adenosine Triphosphate metabolism, Animals, Cell Differentiation drug effects, Cell Proliferation drug effects, Cell Self Renewal drug effects, Cell Survival drug effects, Mice, Mitochondria drug effects, Neural Stem Cells drug effects, Neural Stem Cells metabolism, Neurogenesis drug effects, Oxidation-Reduction, Oxidative Stress drug effects, Amyloid beta-Peptides toxicity, Cell Lineage drug effects, Mitochondria metabolism, Mitochondrial Dynamics drug effects, Neural Stem Cells pathology, Organelle Biogenesis
- Abstract
Alzheimer's disease (AD) is the most common neurodegenerative disease and is characterized by the accumulation of amyloid β peptide (Aβ). Although most AD mouse models present a decline in neurogenesis, they express mutated genes which regulate neurogenesis per se and are not present in most AD patients, thus masking the real impact of Aβ on adult neurogenesis. Mitochondrion, a well-known target of Aβ in neurons, is a main regulator of neural stem cell (NSC) fate. Here, we aimed to investigate the impact of Aβ on NSC mitochondria and cell fate decisions, namely whether and how Aβ affects neurogenesis. NSC fate and mitochondrial parameters, including biogenesis, dynamics, and oxidative stress, were evaluated. Our results showed that Aβ impaired NSC viability and proliferation and indirectly blocked neurogenic differentiation, by disrupting mitochondrial signaling of self-renewing NSCs. Importantly, Aβ decreased ATP levels, generated oxidative stress, and affected the radical scavenger system through SOD2 and SIRT3. Aβ also reduced mtDNA and mitochondrial biogenesis proteins, such as Tfam, PGC-1α, and NRF1, and inhibited activation of PGC-1α-positive regulator CREB. Moreover, Aβ triggered mitochondrial fragmentation in self-renewing NSCs and reduced mitochondrial fusion proteins, such as Mfn2 and ERRα. Notably, Aβ compromised NSC commitment and survival by irreversibly impairing mitochondria and thwarting any neurogenic rescue through mitochondrial biogenesis, dynamics, or radical scavenger system. Altogether, this study brings new perspective to rethink the molecular targets relevant for endogenous NSC-based strategies in AD.
- Published
- 2019
- Full Text
- View/download PDF